Primary Hyperaldosteronism
Endocrinology·MeSH: Hyperaldosteronism
2 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| baxdrostat | ASTRAZENECA PLC (AZN) |
Phase 4(1)
Compare drugs
Frequently asked questions
How many drugs are in development for Primary Hyperaldosteronism?
BioSniper tracks 2 drugs in development for Primary Hyperaldosteronism across 1 company.
How many clinical trials target Primary Hyperaldosteronism?
There are 1 clinical trial targeting Primary Hyperaldosteronism tracked by BioSniper.
Deep-dive into Primary Hyperaldosteronism
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis